Supreme Court allows provisional entry to Rajasthan SI exam, keeps results on hold

New Delhi, April 2 -- The Supreme Court on Thursday granted relief to candidates seeking to appear in the Rajasthan Sub-Inspector (SI)/Platoon Commander Recruitment Examination 2025, permitting them t... Read More

Over 6 lakh passengers return to India amid West Asia conflict, says govt

New Delhi, April 2 -- A senior official from the Government of India informed on Thursday that over 6 lakh passengers have returned to India from the West Asia region amid the developing security situ... Read More

సెన్సెక్స్ 1500 పాయింట్లు పతనం.. లక్షల కోట్లు ఆవిరి! స్టాక్ మార్కెట్ కుప్పకూలడానికి 5 ప్రధాన కారణాలివే

భారతదేశం, ఏప్రిల్ 2 -- భారత స్టాక్ మార్కెట్లు గురువారం ట్రేడింగ్‌లో కుప్పకూలాయి. ఏప్రిల్ 2వ తేదీ ఉదయం నుంచే నష్టాలతో ప్రారంభమైన సూచీలు, సమయం గడిచేకొద్దీ తీవ్ర పతనానికి గురయ్యాయి. బాంబే స్టాక్ ఎక్స్ఛేం... Read More

PlayStation Plus Monthly Games for April Confirmed-Lords of the Fallen, Tomb Raider and More

India, April 2 -- PlayStation Plus Monthly Games for April 2026 have been confirmed by Sony, and the lineup features three games available to all PlayStation Plus members. You can fight powerful enemi... Read More

Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, April 2 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemothera... Read More

Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, April 2 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safet... Read More

Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, April 2 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) M... Read More

Singapore Clinical Trial: DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in combination with atezolizumab, carboplatin, and etoposide vs. atezolizumab, carboplatin, and etoposide as first-line treatment in patients with extensive-stage small cell lung cancer

Singapore, April 2 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig i... Read More

Singapore Clinical Trial: An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of BAY 3771249 as monotherapy or combination with other cancer treatments in participants with solid tumors harboring a KRAS G12D mutation

Singapore, April 2 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and ... Read More

Singapore Clinical Trial: A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of asciminib in pediatric participants newly diagnosed or previously treated with Philadelphia positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) with or without known T315I mutation.

Singapore, April 2 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of ascim... Read More

• ««
• «
• 38660
• 38661
• 38662
• 38663
• 38664
• 38665
• 38666
• 38667
• 38668
• 38669
• »
• »»